Outlook Therapeutics, Inc. (OTLK) — 10-K/A Filings
All 10-K/A filings from Outlook Therapeutics, Inc.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (2)
-
Outlook Therapeutics Files 10-K/A Amendment
— Jan 23, 2025 Risk: medium
Outlook Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended September 30, 2024. The company, formerly known as Oncobio -
Outlook Therapeutics, Inc. Files 10-K/A Amendment for Fiscal Year Ended September 30, 2023
— Jan 24, 2024 Risk: low
Outlook Therapeutics, Inc. (OTLK) filed a Amended Annual Report (10-K/A) with the SEC on January 24, 2024. Outlook Therapeutics, Inc. filed an amendment (10-K/A
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX